ArticleOncotarget2017
Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer.
Paul M Wilkerson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ArticleOncotarget2017
Paul M Wilkerson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.